PRESS RELEASE: Drug Companies Attempt to Use Legislation to Remove Compounded Medications from the Market
A controversial bill concerning compounded drugs is little more than a smokescreen for a power grab by the pharmaceutical industry
A controversial bill concerning compounded drugs is little more than a smokescreen for a power grab by the pharmaceutical industry
OK. If they do, how about dropping the effectiveness test for food or supplements used to treat Alzheimer’s? Action Alert!
Millions rely on compounding pharmacies for natural hormones and other critical drugs. Will we lose them to a congressional/ FDA power play?
Agency begins its promised rewrite after a massive grassroots letter-writing campaign.
Even this limited action is taken only at industry request.
And who’s siding with Monsanto? Phony “food safety advocates” masquerading as political progressives.
In another outrageous power-grab, FDA says your own stem cells are drugs—and stem cell therapy is interstate commerce because it affects the bottom line of FDA-approved drugs in other states!
The USDA’s food safety wing may come under control of the FDA. This will mean more power, wider scope—and greater corruption.
Help us persuade Congress to reform the agency with our Action Alert!
FDA Overreach Threatens New Dietary Ingredients and Supplements ******* Action Alerts For This Campaign ******** Tell the Congress and the FDA: The Draft Guidance on NDIs is Bad for Consumers On July 1, the US Food and Drug Administration issued draft guidance for complying with the New Dietary Ingredient (NDI) notification protocols required by the […]